PAVmed Analyst Ratings
PAVmed Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/20/2023 | 226.87% | Cantor Fitzgerald | $4 → $1.5 | Downgrades | Overweight → Neutral |
| 01/18/2023 | 226.87% | Lake Street | $5 → $1.5 | Maintains | Buy |
| 08/17/2022 | 989.56% | Lake Street | $7 → $5 | Maintains | Buy |
| 03/30/2021 | 1643.3% | Cantor Fitzgerald | → $8 | Initiates Coverage On | → Overweight |
| 11/05/2020 | 989.56% | Ascendiant Capital | → $5 | Initiates Coverage On | → Buy |
| 10/13/2020 | 989.56% | Lake Street | → $5 | Initiates Coverage On | → Buy |
| 06/28/2018 | 989.56% | Maxim Group | → $5 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 01/20/2023 | 226.87% | 康托·菲茨杰拉德 | 4 美元 → 1.5 美元 | 降級 | 超重 → 中性 |
| 01/18/2023 | 226.87% | 湖邊街 | 5 美元 → 1.5 美元 | 維護 | 購買 |
| 2022 年 8 月 17 日 | 989.56% | 湖邊街 | 7 美元 → 5 美元 | 維護 | 購買 |
| 03/30/2021 | 1643.3% | 康托·菲茨杰拉德 | → 8 美元 | 啟動覆蓋範圍 | → 超重 |
| 11/05/2020 | 989.56% | 上升資本 | → 5 美元 | 啟動覆蓋範圍 | → 購買 |
| 10/13/2020 | 989.56% | 湖邊街 | → 5 美元 | 啟動覆蓋範圍 | → 購買 |
| 06/28/2018 | 989.56% | 美心集團 | → 5 美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for PAVmed (PAVM)?
PAVMed (PAVMed) 的目標價格是多少？
The latest price target for PAVmed (NASDAQ: PAVM) was reported by Cantor Fitzgerald on January 20, 2023. The analyst firm set a price target for $1.50 expecting PAVM to rise to within 12 months (a possible 226.87% upside). 3 analyst firms have reported ratings in the last year.
坎特·菲茨杰拉德於 2023 年 1 月 20 日報導了 PAVMED（納斯達克股票代碼：PAVMed）的最新價格目標。該分析師公司設定了 1.50 美元的價格目標，預計 PAOM 將在 12 個月內上升（可能是 226.87％ 的上行情況）。3 家分析師公司在去年報告了評級。
What is the most recent analyst rating for PAVmed (PAVM)?
PAVMed (PAVMed) 的最新分析師評級為何？
The latest analyst rating for PAVmed (NASDAQ: PAVM) was provided by Cantor Fitzgerald, and PAVmed downgraded their neutral rating.
PavMed（納斯達克股票代碼：PAVVM）的最新分析師評級由坎特·菲茨杰拉德提供，PavMed 將其中性評級下調。
When is the next analyst rating going to be posted or updated for PAVmed (PAVM)?
PavMed（PAVMed）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PAVmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PAVmed was filed on January 20, 2023 so you should expect the next rating to be made available sometime around January 20, 2024.
分析師在進行了廣泛的研究後到達股票評級，其中包括通過公共財務報表，與 PavMed 的高管和客戶交談以及收聽盈利電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。PavMed 的最後評級於 2023 年 1 月 20 日提交，因此您應該期望下一個評分將在 2024 年 1 月 20 日左右的某個時候提供。
Is the Analyst Rating PAVmed (PAVM) correct?
分析師等級（PAVm）是否正確？
While ratings are subjective and will change, the latest PAVmed (PAVM) rating was a downgraded with a price target of $4.00 to $1.50. The current price PAVmed (PAVM) is trading at is $0.46, which is out of the analyst's predicted range.
雖然評分是主觀的並且會發生變化，但最新的 PAVMed（PAVMed）評級降級，目標價格為 4.00 美元至 1.50 美元。當前價格 PAVMed（PAVMed）的交易價格為 0.46 美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。